--- title: "Callan Family Office LLC Acquires New Shares in CVS Health Corporation $CVS" type: "News" locale: "en" url: "https://longbridge.com/en/news/296676969.md" description: "Callan Family Office LLC acquired a new position in CVS Health (NYSE:CVS) during Q2, purchasing 164,995 shares valued at approximately $17.07 million. Other institutional investors, including Blue Capital Inc. and OneAscent entities, also increased their stakes. CVS recently reported strong quarterly earnings with $2.58 EPS beating estimates, alongside a dividend announcement of $0.665 per share. Multiple brokerages raised price targets, maintaining an average 'Moderate Buy' rating." datetime: "2026-08-22T08:17:26.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296676969.md) - [en](https://longbridge.com/en/news/296676969.md) - [zh-HK](https://longbridge.com/zh-HK/news/296676969.md) generator: "portal-rs" --- # Callan Family Office LLC Acquires New Shares in CVS Health Corporation $CVS Callan Family Office LLC acquired a new position in CVS Health Corporation (NYSE:CVS - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 164,995 shares of the pharmacy operator's stock, valued at approximately $17,069,000. - One Comment on CVS's Earnings Call Sent the Stock Tumbling Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Blue Capital Inc. acquired a new stake in shares of CVS Health during the 2nd quarter worth about $602,000. Keating Financial Advisory Services Inc. acquired a new position in CVS Health in the second quarter valued at about $130,000. OneAscent Wealth Management LLC acquired a new position in CVS Health in the second quarter valued at about $206,000. OneAscent Family Office LLC purchased a new position in CVS Health during the second quarter worth about $222,000. Finally, OneAscent Financial Services LLC acquired a new stake in shares of CVS Health during the second quarter valued at about $658,000. Hedge funds and other institutional investors own 80.66% of the company's stock. ## CVS Health Price Performance Shares of CVS opened at $93.01 on Friday. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68. The firm's 50 day moving average price is $102.02 and its 200 day moving average price is $88.86. The company has a market cap of $118.96 billion, a P/E ratio of 24.61, a PEG ratio of 0.85 and a beta of 0.61. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. - UnitedHealth Just Gave Wall Street a Clearer Turnaround Signal CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating the consensus estimate of $1.87 by $0.71. The company had revenue of $106.10 billion during the quarter, compared to analysts' expectations of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm's revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the company posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, research analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year. ## CVS Health Dividend Announcement The business also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.9%. CVS Health's dividend payout ratio (DPR) is 70.37%. ## Analysts Set New Price Targets - Eli Lilly Wins Back CVS Health, Reverting Novo's Advantage Several brokerages have recently commented on CVS. Mizuho upped their price objective on shares of CVS Health from $110.00 to $115.00 and gave the stock an "outperform" rating in a report on Monday, June 8th. UBS Group lifted their target price on shares of CVS Health from $122.00 to $126.00 and gave the company a "buy" rating in a report on Thursday, August 6th. Sanford C. Bernstein upped their price target on CVS Health from $94.00 to $106.00 and gave the stock an "outperform" rating in a research note on Tuesday, May 12th. Barclays raised their price target on CVS Health from $106.00 to $108.00 and gave the stock an "overweight" rating in a research report on Thursday, August 6th. Finally, TD Cowen lifted their price objective on CVS Health from $105.00 to $110.00 and gave the company a "buy" rating in a research note on Monday, May 11th. Twenty-two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $107.17. **Get Our Latest Stock Report on CVS** ## CVS Health Company Profile (Free Report) CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities. Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services. ## Featured Articles - Five stocks we like better than CVS Health - Blueprint for a Boom: SEC Clears the Crypto Runway - Ross Stores Just Flipped the Off-Price Retail Story After TJX's Marmaxx Miss - Advance Auto Parts Plunged, But Its Turnaround Is Still Working - Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? **Want to see what other hedge funds are holding CVS?** Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report). *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.* Continue following MarketBeat Add MarketBeat as your preferred source on Google to see our latest stories in your feed. Add As Preferred Source ## Should You Invest $1,000 in CVS Health Right Now? Before you consider CVS Health, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list. While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [CVS.US](https://longbridge.com/en/quote/CVS.US.md) - [UNH.US](https://longbridge.com/en/quote/UNH.US.md) - [LLY.US](https://longbridge.com/en/quote/LLY.US.md) - [NVO.US](https://longbridge.com/en/quote/NVO.US.md) - [MFG.US](https://longbridge.com/en/quote/MFG.US.md) - [8411.JP](https://longbridge.com/en/quote/8411.JP.md) - [UBS.US](https://longbridge.com/en/quote/UBS.US.md) - [BCS.US](https://longbridge.com/en/quote/BCS.US.md) - [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md) - [TD.US](https://longbridge.com/en/quote/TD.US.md) ## Related News & Research - [Archer Investment Corp Buys New Position in CVS Health Corporation $CVS](https://longbridge.com/en/news/297393075.md) - [Oppenheimer Asset Management Inc. Invests $49.62 Million in CVS Health Corporation $CVS](https://longbridge.com/en/news/295999033.md) - [Grainger acquiring AWM in $210 million deal](https://longbridge.com/en/news/297373212.md) - [Callan Family Office LLC Invests $8.55 Million in Abbott Laboratories $ABT](https://longbridge.com/en/news/297479349.md) - [CVS HEALTH CORPORATION REPORTS STRONG FIRST QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE | CVS Stock News](https://longbridge.com/en/news/285356226.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**